Research article · 2013
Research articlePublished 2013
Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1 , DNASE1L3 , DNASE2 , and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer?
Subjects
Genetics & Molecular BiologySimilar by topic
Conference abstract · 19 Nov 2012
Cancer suicide gene therapy: Apoptosis of the ovarian cancer cells induced by EGFRvIII targeted delivery and cell nucleus targeted expression of the DNA-ase transgenes
Research article · 19 Aug 2015
Study of the methylation patterns of the EGFR gene promoter in non-small cell lung cancer
Research article · 25 Apr 2013
Enhancement of recombinant adeno-associated virus mediated transgene expression by targeted echo-contrast agent
Research article · 18 Jun 2015
Recombinant adenovirus-mediated overexpression of PTEN and KRT10 improves cisplatin resistance of ovarian cancer in vitro and in vivo
More from this journal
The newest in Journal of Genetic Syndromes & Gene Therapy.
Commentary · 1 Jul 2026
Mitochondrial Genome Correction Approaches in Rare Energy Deficiency Syndromes
Perspective · 1 Jul 2026
Lentiviral Gene Integration Systems in Hematologic Genetic Blood Disorders
Perspective · 1 Jul 2026
Programmable RNA Editing Systems in Congenital Skeletal Dysplasia Disorders
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Genetic Syndromes & Gene Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Marek Malecki”
- BylineArticles whose byline prints “Jessica Dahlke”
- BylineArticles whose byline prints “Melissa Haig”
- BylineArticles whose byline prints “Lynn Wohlwend”
- BylineArticles whose byline prints “Raf Malecki”

